DS-1040b + Clopidogrel

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
33
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Drug Interaction

Conditions

Drug Interaction

Trial Timeline

Dec 1, 2015 โ†’ Mar 1, 2016

About DS-1040b + Clopidogrel

DS-1040b + Clopidogrel is a phase 1 stage product being developed by Daiichi Sankyo for Drug Interaction. The current trial status is completed. This product is registered under clinical trial identifier NCT02560688. Target conditions include Drug Interaction.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT02560688Phase 1Completed